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What is already known: 
Obesity increases the risk of physical inactivity, poor functional performance and 
 mobility limitations. 
No previous studies have evaluated the longitudinal relationship between abdominal 
obesity and the onset of frailty 
What does this study add: 
Both general and abdominal obesity are associated with incident frailty and with risk of 
exhaustion, low physical activity and weakness in the elderly. 
Systemic inflammation and insulin-resistance exert only a modest physio-pathological 
influence on the risk of frailty in obese individuals. 
  
 
 
 
ABSTRACT 
Objectives: To evaluate for the first time the longitudinal relationship between 
abdominal obesity and the onset of frailty.  
Methods: Study based on results from two population-based cohorts, the Seniors- 
ENRICA, with 1801 individuals aged ≥60, and the TSHA, with 1289 participants ≥65 
years. Incident frailty was assessed with the Fried criteria. 
Results: During 3.5 years of follow-up, we identified 125 individuals with incident 
frailty in the Seniors-ENRICA and 162 in the TSHA. After adjustment for the main 
confounders, the pooled odds ratio (pooled-OR) for general obesity and risk of frailty 
was 1.73 (95% confidence interval [CI]: 1.18-2.28). Abdominal obesity was also 
associated with frailty (pooled OR: 1.67; 95%CI: 1.09-2.25). Compared to individuals 
with BMI <25 kg/m2 and no abdominal obesity, the risk of frailty was highest among 
individuals with concurrent general and abdominal obesity (pooled OR: 2.55; 95%CI: 
1.23-3.86). General obesity was associated with increased risk of exhaustion (pooled 
OR: 1.66; 95%CI: 1.11-2.21), low physical activity (pooled OR: 1.57; 95%CI: 1.08-
2.05) and weakness (pooled OR: 1.63; 95%CI: 1.12-2.05). For abdominal obesity, 
results were in the same direction, although they showed statistical significance only for 
weakness (OR: 1.46; 95%CI: 1.11-1.80). 
Conclusions: General and abdominal obesity are associated with incident frailty in the 
elderly.  
Key words: Abdominal obesity, aging, cohort study, frailty, obesity
  
 
 
 
INTRODUCTION 
Older adults are a growing segment of the population in most countries. Accordingly, 
the number of persons with disability and dependence is also likely to increase over the 
next decades. Frailty is an age-associated syndrome characterized by dysfunction of 
multiple systems, reduced functional reserve and increased vulnerability to 
environmental stressors. As a consequence, frail individuals are at increased risk of 
illness, disability, institutionalization and death (1). Thus, a better understanding of the 
pathogenesis of frailty and improved prevention strategies could serve to reduce or 
delay disability (2). 
The prevalence of overweight and obesity in older adults is very high in many countries 
(3). There is evidence that obesity in the elderly increases the risk of physical inactivity 
(4;5), poor functional performance (6) and mobility limitations (7). However, studies on 
the link between obesity, fat distribution and frailty are scarce (8-11), and no previous 
research has focused on the longitudinal relationship between abdominal obesity and the 
onset of this syndrome.  
The adipose tissue is a metabolically active organ that secretes numerous pro-
inflammatory cytokines. In a recent meta-analysis, body mass index (BMI) and waist 
circumference (WC) were associated with elevated concentrations of the inflammatory 
marker C-reactive protein (CRP) (12). Systemic inflammation has also been identified 
as a risk factor for frailty (13), but its potential role in mediating the association 
between obesity and frailty has not been addressed prospectively. Similarly, despite the 
  
 
 
 
evidence that visceral adiposity and insulin resistance are closely linked (14;15) and that 
insulin resistance is associated with the risk of frailty (13), no studies have evaluated the 
contribution of this metabolic disorder to the development of obesity-related frailty. 
In this context, this study assessed the prospective association of general and abdominal 
obesity with the risk of frailty and its components. Additionally, it explored the 
mediating role of CRP and insulin-resistance in the relationship between obesity and 
frailty. Lastly, with the aim of assessing the consistency of results, the analyses were 
conducted in two independent population-based cohorts of older adults in Spain, the 
Seniors-ENRICA and the Toledo Study for Healthy Ageing (TSHA). 
SUBJECTS AND METHODS 
Study population and design 
Seniors-ENRICA  
From 2008 to 2010, 2614 men and women were selected through stratified random 
sampling from the non-institutionalized Spanish population aged 60 years and older 
(2;16). Information at baseline was collected in three stages. First, computer-assisted 
telephone interviews were used to obtain information on socio-demographic factors, 
health behaviors and morbidity. Then, two home visits were performed to collect blood 
and urine samples, conduct a physical examination and record usual diet and prescribed 
medication. Participants were followed-up until 2012 (mean follow-up time of 3.5 
years), when a second wave of data collection was performed, again including again a 
  
 
 
 
phone interview, a physical exam, and diet and medication assessment at home. Ninety-
five participants (3.6%) died during follow-up. From the remaining 2519 subjects, 2085 
had complete information on frailty at the end of follow-up. Baseline socio-
demographic, lifestyle and clinical characteristics of individuals lost to follow-up and 
those remaining in the study were similar, although the latter were slightly younger, had 
higher educational level and fewer comorbidities. From these 2085 individuals, we 
further excluded 174 who either lacked information on frailty or were frail at baseline, 
45 without complete data on anthropometry and 65 with missing information on 
potential confounders, leading to a final sample of 1801 participants. 
Participants in the Seniors-ENRICA gave written informed consent. The Clinical 
Research Ethics Committee of the ‘La Paz’ University Hospital in Madrid approved the 
study.  
TSHA  
The original cohort was recruited between 2006 and 2009. It consisted of 2488 
participants ≥65 years of age selected by two-stage random sampling from the 
municipal census of Toledo (Spain), covering both institutionalized and community-
dwelling persons from urban and rural settings (17;18). Two home visits were 
performed to conduct computer-assisted interviews and a physical examination on 1972 
participants. In a third stage, study participants went to their health center to provide 
blood samples. A new wave of data was collected from each individual after a mean 
follow-up of 3.5 years. Two hundred participants died during follow-up. From the 
  
 
 
 
remaining 1772 participants who had undergone both the interview and physical 
examination, we excluded 211 participants who lacked information on frailty at 
baseline, 203 who were frail at baseline, and 69 without complete data on 
anthropometry or with missing information on any of the potential confounders. Thus, 
the analyses were conducted with 1289 individuals. Study participants provided written 
consent, and the study was approved by the Clinical Research Ethics Committee of the 
Hospital of Toledo. 
Study variables 
Anthropometry 
At baseline in the two cohorts, weight, height and WC were measured in each subject. 
These measurements were performed using electronic scales (model Seca 841, precision 
to 0.1 kg), portable extendable stadiometers (model Ka We 44 444Seca) and flexible, 
inelastic belt-type tapes, respectively. Measurements were taken twice by trained staff 
under standardized conditions (19). Mean values of the two measurements were used 
for the analyses. BMI was calculated as weight in kg divided by square height in m. 
Normal weight was defined as BMI 18.5-24.9 kg/m2, overweight as BMI 25-29.9 
kg/m2, and general obesity as ≥30 kg/m2. Abdominal obesity was defined as WC >102 
cm in men and >88 cm in women. 
Frailty 
  
 
 
 
In both cohorts, frailty was assessed at baseline and end of follow-up with a slight 
modification of the criteria proposed by Fried et al.19 Individuals meeting three or more 
of the following five phenotypic criteria were considered as frail: 1) Self-reported 
exhaustion, defined as any of the following responses to two questions taken from the 
Center for Epidemiologic Studies Depression Scale20: “I felt that anything I did was a 
big effort” or “ I felt that I could not keep on doing things” at least 3 to 4 days a week; 
2) Weight loss, defined as unintentional loss of ≥4.5 kg of body weight in the preceding 
year; 3) Low physical activity, defined as walking ≤2.5 h/week in men and ≤2 h/week in 
women in the Seniors-ENRICA, and the worst quintile in the PASE scale, adjusted for 
sex, in the TSHA (20); 4) Weakness, defined as the cohort-specific  lowest quintile of 
grip strength measured with a Jamar dynamometer and adjusted for sex and body mass 
index (21). The highest value in two consecutive measures was used in the analyses; 
and 5) Slow walking speed, defined as the worst cohort-specific quintile in the three-
meter walking speed test, adjusted for sex and height (22). 
CRP and insulin resistance 
In both cohorts, participants provided 12-h fasting blood samples. High sensitivity CRP 
was determined by latex-enhanced nephelometry. The Homeostasis model assessment 
(HOMA-IR) was used to evaluate insulin resistance using the formula: fasting serum 
insulin (µU/mL) X fasting plasma glucose (mg/dL) / 405. Glucose was measured by the 
glucose oxidase method, and insulin by immunoenzymatic assay. 
Other variables 
  
 
 
 
At baseline, self-reported information was obtained in the two cohorts on age, sex 
educational level, tobacco and alcohol consumption, and physical activity (using the 
EPIC-cohort questionnaire for activity at work and at leisure time in the Seniors- 
ENRICA, and the PASE scale in the TSHA). Participants also reported their drug 
treatment, which was checked by the study staff against drug packages at home. The 
Lawton-Brody index was used to ascertain limitations in instrumental activities of daily 
living (IADL); the questions on subjects’ ability to prepare meals, do household chores, 
and care for clothing were excluded in men. The presence of limitation in at least one 
IADL was considered as disability. Lastly, participants were also asked if they suffered 
from any of the following physician-diagnosed diseases: cardiovascular disease 
(ischemic heart disease, stroke or heart failure), diabetes, cancer, asthma or chronic 
bronchitis, and osteo-articular disease (defined as osteoarthritis, arthritis or hip fracture 
in the Seniors-ENRICA, and as hip or knee osteoarthritis or arthritis in the TSHA).  
Additionally, in the Seniors-ENRICA cohort, food consumption was assessed at 
baseline with a validated computerized diet history developed from that used in the 
EPIC-Spain cohort study, and energy intake was calculated with standard food 
composition tables (23). Adherence to the Mediterranean diet was summarized using 
the Mediterranean Diet Adherence Screener (MEDAS) index. 
Statistical analysis 
The association of BMI and WC with frailty was evaluated with odds ratios (OR) and 
their 95% confidence intervals (CI) obtained from logistic regression models with 
  
 
 
 
progressive levels of adjustment. Model 1adjusted for sex, age and educational level; 
model 2 further adjusted for behavioral risk factors (tobacco and alcohol consumption, 
physical activity, diet quality and energy intake); model 3 additionally included chronic 
diseases and drug treatments, while model 4 also adjusted for WC (when BMI was the 
main independent variable) or BMI (when WC was the main independent variable). In a 
fifth step, models were further adjusted for CRP and HOMA-IR when this information 
was available (n=1770 in Seniors-ENRICA, and n= 858 in TSHA), to investigate the 
mediating role of these variables in the association between obesity and frailty.  
To assess the joint and independent effects of overall and central obesity on the risk of 
incident frailty, we classified subjects into six groups according to categories of BMI 
(<25, 25-29, ≥30) and WC (≤102 and >102 in men, ≤88 and >88 in women). We then 
created a dummy variable with six categories and introduced it in a logistic regression 
model that contained the same adjustment variables as in model 3.  
Next, we estimated the association between obesity and onset of each frailty criterion 
among robust adults (free of all five criteria) at baseline. Again these analyses were 
adjusted as in model 3 above. 
Between-study heterogeneity was assessed using the DerSimonian-Laird-chi square 
based Q statistic and quantified using the I2 statistic. Given that the results in the 
Seniors-ENRICA and TSHA were generally consistent (I2<30%),  they were pooled 
using random-effects meta-analysis as implemented in STATA using the metan 
command (24).   
  
 
 
 
The following sensitivity analyses were performed. First, we stratified the results by age 
and sex.  Second, we repeated the main analyses excluding the weight loss criteria from 
the definition of frailty and considering as frail those with ≥2 of the 4 remaining criteria. 
For this analysis we also excluded individuals with frailty at baseline according to the 
new definition. Finally, we studied the association of BMI and WC with risk of incident 
frailty after excluding individuals with limitation in IADL.  
RESULTS 
Tables 1 and 2 show the main socio-demographic, lifestyle and clinical characteristics at 
baseline, among the participants in the two study cohorts. Participants in the TSHA 
study were older, had lower educational level, were more frequently obese and 
presented a higher frequency of chronic diseases when compared to those in the 
Seniors-ENRICA. In both cohorts, women, participants with lower educational, as well 
as those diagnosed with diabetes or osteoarticular disease showed the highest 
prevalence of obesity, while current smokers and those diagnosed with cancer were 
more likely to be in the lowest categories of BMI and WC. PCR and HOMA-IR values 
increased from normal weight to obese. 
During 3.5 years of follow-up, 125 individuals in the Seniors-ENRICA and 162 from 
the TSHA developed frailty. Table 3 shows the main results of the study. After 
adjustment for the main potential confounders (model 3), a BMI under 25 was 
associated with an increased risk of frailty in the TSHA (OR: 1.69; 95%CI: 1.01-2.83) 
but not in the Seniors-ENRICA (OR: 0.85; 95%CI: 0.44-1.65). In both cohorts, general 
  
 
 
 
and abdominal obesity were positively related to the risk of frailty. In model 3, the 
pooled OR for general obesity and risk of frailty was 1.73 (95%CI: 1.18-2.28). This 
association was attenuated when WC was included in the model, indicating that part of 
the association between BMI and frailty could be mediated through abdominal 
adiposity.  An increased risk of frailty was also observed among individuals with 
abdominal obesity (pooled OR: 1.67; 95%CI: 1.09-2.25); this association was slightly 
reduced when accounting for BMI (OR: 1.61; 95%CI: 0.95-2.26). Adjustment for 
potential mediators (HOMA-IR and CRP) also attenuated the observed associations, so 
that the pooled OR for general obesity was 1.38 (95%CI: 0.86-1.90) and for central 
obesity was 1.62 (95% CI: 0.96-2.28). To analyze the percentage change in the 
magnitude of the ORs, we also calculated the pooled effects for model 4 after excluding 
participants with no information on potential mediators (data not shown in tables); and 
estimated that inclusion of HOMA-IR and CRP yielded a 6.8% and 1.2% change in the 
ORs  for general and central obesity, respectively. 
Stratification of participants by categories of BMI (<25/ 25-29.9/ ≥30) and WC (≤102 
men, ≤88 women / >102 men, >88 women) showed that, compared to individuals in the 
lowest category of BMI and WC, the risk of frailty was highest among individuals with 
concurrent general and abdominal obesity (pooled OR: 2.55; 95%CI: 1.23-3.86) (table 
4).  
Table 5 shows the effect of obesity on the five components of the frailty syndrome.  In 
both cohorts, the most common components were weak grip strength and low physical 
  
 
 
 
activity, while unintentional weight loss was the least frequent component. Results from 
the pooled analyses showed that a BMI ≥30 was associated with an increased risk of 
exhaustion (OR: 1.66; 95%CI: 1.11-2.21), low physical activity (OR: 1.57; 95%CI: 
1.08-2.05) and weakness (OR: 1.63; 95%CI: 1.22-2.05). With abdominal obesity, 
results were in the same direction, although only for weakness they showed statistical 
significance (OR: 1.46; 95%CI: 1.11-1.80). Unexpectedly, a BMI<25 was inversely 
associated with the risk of weakness in the Seniors-ENRICA (OR: 0.68; 95%0.48-0.97), 
but not in the TSHA cohort (OR: 1.71; 95%CI: 0.92-3.16).  
Results from the sensitivity analyses are shown in Supplemental material, tables S1-S2.  
Some evidence of effect modification by age and sex was observed in the Seniors-
ENRICA cohort: while the strongest effect of general obesity and frailty was seen 
among those aged ≤75, the association with WC was limited to women. Overall, the 
pooled-OR for the association between abdominal obesity and the risk of frailty in 
women was 2.26 (95%CI: 1.04-3.48).  Finally, restriction of the analyses to those 
individuals with no limitation in IADL at baseline weakened the positive association 
with BMI<25, whereas it strengthened the association with general and abdominal 
obesity. 
DISCUSSION 
Results from the Seniors-ENRICA and TSHA cohort studies show that both general and 
abdominal obesity are associated with incident frailty in the elderly, and suggest an 
  
 
 
 
independent association between obesity and risk of exhaustion, low physical activity 
and weakness.  
Previous epidemiologic studies have explored the association between BMI and frailty. 
In 2005, a cross-sectional analysis on 599 community-dwelling women aged 70 to 79 
from the Women´s Health and Aging Studies I (1992) and II (1994) first showed a 
positive link between obesity and frailty (8). That same year, data from 40,657 women 
aged 65 to 79 who participated in the Women´s Health Initiative and were followed-up 
for three years, confirmed that being overweight or obese increased the risk of frailty 
(9). Lately, a study based on 4732 participants ≥60 years from the Third National Health 
and Nutrition Examination Survey (NHANES) found that the prevalence of frailty was 
highest among people who were obese (BMI ≥30) and lowest among those who were 
underweight (BMI <18.5) (25). More recently, the effects of midlife obesity have been 
evaluated and results suggest that maintaining a healthy weight throughout life may 
contribute to prevention of frailty later in time (10;26). 
Despite the emerging evidence linking obesity and frailty, the association between 
central obesity and risk of frailty has been largely unexplored, and only two previous 
studies partially addressed this issue. The first of these, which was based on 2826 
participants from the Cardiovascular Health Study, showed a higher crude prevalence of 
central adiposity at baseline in individuals who developed frailty during follow-up (13). 
The second study, which used data from 3055 community-dwelling adults aged 65 years 
and older, showed a cross-sectional positive association between WC and frailty (11). 
  
 
 
 
Our results confirm that WC predicts incident frailty, particularly among individuals 
with a BMI ≥30 kg/m2 and among women. 
Body composition changes with age, decreasing lean mass and increasing fat mass, and 
muscle fat infiltration (27). As a consequence, there is a likely an underestimation of 
adiposity by BMI, which is more pronounced with ageing (28;29), and is greater at 
lower BMI values (29). Data from the TSHA suggested an increased risk of frailty in 
individuals with a BMI <25, which has also been reported in previous studies (11), but 
was not confirmed in the Seniors-ENRICA cohort or in the III NHANES (25) . 
Although further research is warranted to better understand the relationship between 
BMI and frailty in normo- and under-weight individuals, differences in age between the 
studied cohorts (i.e individuals from the TSHA cohort were on average five years older 
than those from the Seniors-ENRICA) may contribute to the discrepancy in the 
observed results. 
When the relationship between obesity and risk of each frailty component was assessed, 
a significant association was limited to the most common items: grip strength, low 
physical activity and exhaustion. An inverse relationship between obesity and grip 
strength in the elderly has been previously described (30;31), and is attributed to fat 
infiltration of the muscle secondary to obesity and obesity-related inactivity (32;33) . 
Conversely, studies evaluating the link between obesity and exhaustion are less 
common and generally investigate the inverse hypothesis, i.e., how vital exhaustion 
affects subsequent risk of obesity, with conflicting results (34;35). In contrast to the 
  
 
 
 
existing literature (36;37), we did not find a positive association between obesity and 
walking speed. 
A study on 2021 men and women ≥55 years from the population-based Health 2000 
Survey in Finland previously explored the role of inflammation and insulin resistance as 
mediating factors in the association between obesity and hand grip strength (30). 
Similar to what we observed for frailty, adjustment for CRP and IR-HOMA resulted in 
a slight attenuation of the associations, suggesting that systemic inflammation and 
insulin-resistance exert only a modest physio-pathological influence on the risk of hand 
grip strength and frailty in obese individuals.  
Strengths of this study include its prospective design and the consistency of the results 
across heterogeneous cohorts. Moreover, our results were robust to different sensitivity 
analyses and to adjustment for an extensive list of potential confounding factors. 
Limitations of this study should also be noted. First, the study results are limited by the 
sample size, particularly when evaluating the associations stratified by participants’ 
characteristics. However, thanks to the consistency of the results, pooled estimates 
could be calculated, which increased the precision of the observed effects. Second, 
although we have information on many confounders, we cannot rule out some residual 
confounding due to comorbid conditions. Third, we cannot rule out the possibility that 
inflammation markers other than CRP (e.g., interleukin 6, leukocyte count, etc.) could 
mediate the association between obesity and frailty. This hypothesis should be 
investigated in the future. Finally, there is increasing evidence that obesity throughout 
  
 
 
 
the life course is independently associated with the risk of certain frailty components, 
but we could not take into account the effect of early life anthropometric factors on the 
studied associations. 
Several clinical trials have evaluated the effects of a combination of diet therapy and 
exercise in obese older adults (38-40). Results from these trials show that this strategy 
produces clinically significant reductions in body mass while improving physical 
function. Future research should assess whether appropriate interventions addressing 
obesity can reduce the risk of frailty and the subsequent disability.  
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Table 1.  
 
Baseline characteristics of participants in the Seniors-ENRICA study by categories of body mass index (BMI) 
and waist circumference (WC). N=1801. 
 
Main characteristics BMI (Kg/m2) Waist circumference (cm) 
 <25 
n=354 
25-29.9 
n=897 
≥30 
n=550 
≤102 men 
 ≤88 women 
n=778 
>102 men,  
>88 women 
n=1023 
Socio-demographic 
factors 
     
Male 39.8 52.5 47.6 56.2 42.7 
Age 68.3 (6.6) 68.7 
(6.4) 
68.7 
(6.0) 
67.9 (6.3) 69.2 (6.3) 
Educational level      
≤Primary 41.8 51.6 63.6 43.7 60.7 
Secondary 27.7 25.8 21.6 29.3 21.5 
University 30.5 22.6 14.7 27.0 17.8 
Lifestyle behaviors/diet      
Smoking  62.4 54.8 58.9 54.9 59.6 
Never 23.7 32.3 32.9 30.6 30.9 
Former 13.8 12.9 8.2 14.5 9.5 
Current      
Alcohol consumption      
Never 34.7 32.7 38.2 32.1 36.8 
Former 8.5 8.1 8.0 7.2 8.9 
Moderate drinkersa 52.5 50.4 43.5 53.3 45.2 
Excessive drinkersa 4.2 8.8 10.4 7.3 9.2 
Physical activity      
At work      
Non worker 53.1 59.3 56.5 60.4 54.8 
Sedentary 12.1 10.5 16.9 11.3 13.9 
Standing 33.9 28.5 25.1 26.7 29.9 
Manual 0.8 1.7 1.5   
Recreational (MET) 24.4 
(16.4) 
22.0 
(14.8) 
19.5 
(15.3) 
24.5 (16.0) 19.6 (14.5) 
Diet      
MEDAS (tertiles)b      
≤6 women; ≤7men 39.5 42.9 47.5 40.2 46.2 
7-8 women; 8 men 34.7 32.4 32.2 33.0 32.6 
≥9 women and men 25.7 24.6 20.4 26.7 21.1 
Energy intake (kcal/day) 20.0 (5.5) 20.3 
(5.4) 
20.5 
(6.2) 
20.4 (5.5) 20.3 (5.8) 
Morbidity      
Cardiovascular diseasec 6.2 4.2 6.2 4.9 5.5 
Diabetes 8.5 13.3 22.2 9.4 19.4 
Cancer 2.5 2.0 1.1 2.3 1.5 
Asthma or chronic 
bronchitis 
6.8 7.6 8.2 5.5 9.2 
Osteoarticular diseased 41.0 44.0 56.4 39.2 53.3 
Number of drugs  1.4 (1.6) 1.8 (1.9) 2.5 (2.1) 1.5 (1.7) 2.2 (2.0) 
C-reactive protein 
(mg/dl)e 
0.3 (0.4) 0.4 (0.7) 0.5 (0.8) 0.3 (0.6) 0.4 (0.8) 
HOMA-IR f 1.6 (1.3) 2.4 (3.2) 3.4 (2.7) 1.9 (1.8) 3.1 (3.4) 
Data in tables are percentages for categorical variables and means (SD) for continuous variables.  
a Moderate drinker: alcohol intake >0 to 20 g/day; excessive drinker: alcohol intake >20 g/day.  
b MEDAS: Mediterranean Diet Adherence Screener (range 0-14) 
c Self-reported ischemic heart disease, stroke or heart failure 
d Self-reported osteoarthritis, arthritis or hip fracture 
  
 
 
 
e Six participants had no information available; N=1795  
f Nineteen participants had no information available; N=1782 
  
 
 
 
Table 2.  
Baseline characteristics of the participants in the Toledo Study on Healthy Aging by categories of body mass 
index (BMI) and waist circumference (WC). N=1289. 
Main characteristics
  
 BMI  (Kg/m2)  Waist circumference (cm) 
 <25 
n=191 
25-29.9 
n=584 
≥30 
n=514 
 ≤102 men, 
≤88 women 
n=430 
>102 men,  
>88 women 
n=859 
Socio-demographic 
factors 
      
Male 49.7 47.6 31.9  66.3 29.3 
Age 75.3 (5.9) 74.3 (5.4) 73.5 (4.7)  74.2 (5.4) 74.1 (5.2) 
Educational level       
None 63.8 62.2 70.5  64.2 66.5 
<Primary 16.5 18.3 17.2  16.4 18.2 
≥Primary 19.7 19.5 12.3  19.4 15.3 
Lifestyle behaviors/diet       
Smoking        
Never 85.9 87.4 93.6  81.7 93.0 
Former 0.7 2.1 1.7  2.5 1.4 
Current 13.4 10.5 4.7  15.8 5.6 
Alcohol consumption       
Never 80.4 75.9 81.7  70.7 83.0 
Former 0.5 1.2 1.6  1.6 1.1 
Moderate drinkers 18.4 22.2 16.5  26.7 15.6 
Excessive drinkers 0.7 0.7 0.2  1.0 0.3 
Physical activity       
PASE score 77.52 
(45.2) 
77.25 
(44.6) 
78.19 
(46.4) 
 81.33 (48.4) 75.83 (43.7) 
Morbidity       
Cardiovascular diseaseb 13.2 12.2 15.8  14.0 13.6 
Diabetes 17.9 18.3 19.5  16.1 20.5 
Cancer 8.9 3.6 6.0  6.3 4.9 
Asthma or chronic 
bronchitis 7.9 7.0 6.8 
 
7.5 6.9 
Osteoarticular diseasec 22.2 29.2 39.5  21.6 37.7 
Number of drugs 4.2 (2.9) 4.2 (2.9) 4.3 (2.8)  4.3 (2.8) 4.2 (2.8) 
C-reactive protein 
(mg/dl)d 0.4 (0.5) 0.4 (0.6) 0.5 (0.5) 
 
0.4 (0.4) 0.5 (0.6) 
HOMA-IR e 1.7 (1.2) 2.4 (1.4) 3.1 (1.9)  2.0 (1.2) 2.9 (1.8) 
 
Data in tables are percentages for categorical variables and means (SD) for continuous variables.  
a Moderate drinker: alcohol intake >0 to 20 g/day; excessive drinker: alcohol intake >20 g/day.  
bSelf-reported ischemic heart disease, stroke or heart failure 
c Self-reported hip or knee osteoarthritis or arthritis. 
d Four hundred and thirty one participants had no information available; N=858  
e Three hundred and thirty one participants had no information available; N=958 
  
 
 
 
Table 3.  
 
Association of body mass index (BMI) and waist circumference (WC) with risk of frailty during a 3.5-year follow-
up of older adults.  
 
Study cohort BMI (kg/m2) WC (cm) 
 
<25 25-29.9 ≥30 
≤102 men, 
≤88 women 
>102 men, 
>88 women 
Seniors-ENRICA  
 
   
Frailty; n events/total 14/354 47/897 64/550 24/778 101/1023 
Model 1, OR (95% CI) 0.74 (0.39-1.39) Ref. 2.38 (1.57-3.60) Ref. 2.65 (1.65-4.24) 
Model 2, OR (95% CI) 0.80 (0.42-1.55) Ref. 1.86 (1.20-2.88) Ref. 2.17 (1.32-3.56) 
Model 3, OR (95% CI) 0.85 (0.44-1.65) Ref. 1.66 (1.06-2.60) Ref. 1.93 (1.07-3.19) 
Model 4, OR (95% CI) 1.05 (0.51-2.17) Ref. 1.42 (0.88-2.29) Ref. 1.63 (0.88-3.01) 
Model 5, OR (95% CI) 1.01 (0.51-1.99) Ref. 1.57 (0.99-2.49) Ref. 1.68 (1.00-2.79) 
Toledo Study on Healthy Aging      
Frailty, n events 32/191 60/584 70/514 42/430 120/859 
Model 1, OR (95% CI) 1.52 (0.93-2.51) Ref. 1.76 (1.18-2.63) Ref. 1.70 (1.12-2.60) 
Model 2, OR (95% CI) 1.56 (0.94-2.57) Ref. 1.86 (1.23-2.80) Ref. 1.65 (1.07-2.52) 
Model 3, OR (95% CI) 1.69 (1.01-2.83) Ref. 1.80 (1.19-2.74) Ref. 1.56 (1.02-2.41) 
Model 4, OR (95% CI) 2.47 (1.36-4.53) Ref. 1.60 (1.03-2.47) Ref. 1.59 (0.96-2.64) 
Model 5, OR (95% CI) 1.42 (0.70-2.90) Ref. 1.21 (0.69-2.13) Ref. 1.55 (0.85-2.81) 
Meta-analysis (random effects)      
Failty, n events 46/545 107/1481 134/1064 66/1208 221/1882 
Model 1, OR (95% CI) 0.96 (0.54-1.39)† Ref. 1.97 (1.38-3.56) Ref. 1.93 (1.29-2.58) 
Model 2, OR (95% CI) 1.05 (0.58-1.51)† Ref. 1.86 (1.29-2.43) Ref. 1.78 (1.17-2.39) 
Model 3, OR (95% CI) 1.11 (0.60-1.61) † Ref. 1.73 (1.18-2.28) Ref. 1.67 (1.09-2.25) 
Model 4, OR (95% CI) 1.36 (0.62-2.09) † Ref. 1.51 (1.00-2.01) Ref. 1.61 (0.95-2.26) 
Model 5, OR (95% CI) 1.14 (0.52-1.75) † Ref. 1.38 (0.86-1.90) Ref. 1.62 (0.96-2.28) 
 
Categories of adjustment variables are as in table 1 for the Seniors-ENRICA cohort and as in table 2 for the Toledo 
Study on Healthy Aging. 
Model 1: Adjusted for sex, age, and educational level. 
Model 2: Adjusted additionally for tobacco and alcohol consumption, physical activity, diet quality (MEDAS) and 
energy intake (in the TSHE no adjustment made was made for MEDAS and energy intake) 
Model 3: Adjusted additionally for cardiovascular disease, diabetes, cancer, asthma or chronic bronchitis, 
osteoarticular disease, and number of drug treatments 
Model 4: Model 3 adjusted for WC (when BMI is the main independent variable) or BMI (when WC is the main 
independent variable). 
Model 5: Model 3 adjusted for CRP and HOMA-IR. Model based on 1782 (Seniors-ENRICA) or 858 (Toledo Study 
on Healthy Aging) participants with this information available.  
† I2 ≥30%; Data should be interpreted with caution. 
 
BMI: Body Mass Index; CI: Confidence interval; OR: Odds ratio; Ref: Reference; WC: Waist Circumference. 
  
 
 
 
Table 4.  
 
Odds ratio (95 % confidence interval) of frailty risk according to body mass index (BMI) and waist 
circumference (WC).  
 
 
Study cohort WC (cm) BMI (kg/m2) 
  <25 25-29.9 ≥30 
Seniors-ENRICA     
 ≤102 men, ≤88 women 
1.25 (0.52-
2.98) 
Ref. NAa 
 n events/total 13/446 11/307 0/25 
     
 
>102 men,  >88 
women 
NAa 
1.75 (0.97-
3.54) 
2.46 (1.26-
4.81) 
 n events/total 3/44 34/451 64/525 
Toledo Study on Healthy 
Aging 
    
 ≤102 men, ≤88 women 
1.84 (0.86-
3.91) 
Ref. NAa 
 n events/total 23/163 16/236 3/31 
     
 
>102 men,  >88 
women 
NAa 
2.13 (1.07-
4.24) 
2.65 (1.35-
5.25) 
 n events/total 8/28 44/348 67/483 
Meta-analysis (random effects) 
 
 
 
 ≤102 men, ≤88 women 
1.48 (0.53-
2.44) 
Ref. - 
 n events/total 36/609 27/543  
     
 
>102 men,  >88 
women 
- 
1.90 (0.90-
2.90) 
2.55 (1.23-
3.86) 
 n events/total  78/799 131/1008 
 
Analyses are adjusted as in model 3 in table 3. Categories of adjustment variables are as in table 1 for the Seniors-
ENRICA cohort and as in table 2 for the Toledo Study on Healthy Aging.  
aNA: Not calculated due to the small number of events in these categories (N<10).  
 
BMI: Body Mass Index; Ref: Reference; WC: Waist Circumference. 
 
  
 
 
 
Table 5.  
Association of body mass index (BMI) and waist circumference (WC) with risk of each frailty criterion among 
robust older adults at baseline followed during 3.5 years.  
Study cohort BMI (kg/m2) WC (cm) 
 
<25 25-29.9 ≥30 
≤102 men,  
≤88 women 
>102 men, 
 >88 women 
Seniors-ENRICA  
 
   
Exhaustion; n events/total 30/302 56/732 47/395 49/676 84/753 
OR (95% CI) 1.34 (0.82-2.19) Ref. 1.66 (1.08-2.57) Ref. 1.31 (0.88-1.95) 
 
Low physical activity; n events/total 32/302 89/732 70/395 75/676 116/753 
OR (95% CI) 0.93 (0.59-1.46) Ref. 1.48 (1.03-2.14) Ref. 1.21 (0.86-1.70) 
Slow walking speed; n events/total 43/300 84/728 47/391 78/671 96/748 
OR (95% CI) 1.57 (1.03-2.38) Ref. 0.91 (0.61-1.37) Ref. 0.92 (0.65-1.31) 
Weight loss; n events/total 20/298 47/725 32/392 38/671 61/744 
OR (95% CI) 1.10 (0.62-1.93) Ref. 1.09 (0.66-1.79) Ref. 1.08 (0.68-1.69) 
Weakness; n events/total 64/300 212/731 151/395 156/674 271/752 
OR (95% CI) 0.68 (0.48-0.97) Ref. 1.56 (1.16-2.08) Ref. 1.52 (1.17-1.98) 
Toledo Study on Healthy Aging (TSHE)      
Exhaustion; n events/total 11/96 43/344 54/273 22/254 86/459 
OR (95% CI) 0.89 (0.43-1.86) Ref. 1.66 (1.04-2.64) Ref. 2.18 (1.26-3.77) 
Low physical activity; n events/total 20/97 49/348 46/275 39/254 76/466 
OR (95% CI) 1.56 (0.81-3.02) Ref. 1.84 (1.10-3.08) Ref. 1.54 (0.92-2.57) 
Slow walking speed; n events/total 6/97 33/348 21/271 20/253 40/463 
OR (95% CI) NAa Ref. 0.92 (0.49-1.73) Ref. 1.07 (0.55-2.07) 
Weight loss; n events/total 13/97 27/346 26/272 23/253 43/462 
OR (95% CI) 1.65 (0.78-3.49) Ref. 1.18 (0.65-2.15) Ref. 0.90 (0.50-1.63) 
Weakness; n events/total 20/97 46/341 54/273 41/250 79/461 
OR (95% CI) 1.71 (0.92-3.16) Ref. 1.94 (1.22-3.10) Ref. 1.30 (0.82-2.08) 
Meta-analysis (random effects)      
Exhaustion; n events/total 41/398 99/1076 101/668 71/930 170/1212 
OR (95% CI) 1.12 (0.63-1.62) Ref. 1.66 (1.11-2.21) Ref. 1.44 (0.95-1.94) 
Low physical activity; n events/total 52/399 138/1080 116/670 114/930 192/1219 
OR (95% CI) 1.01 (0.61-1.42) Ref. 1.57 (1.08-2.05) Ref. 1.28 (0.90-1.65) 
Slow walking speed; n events/total  117/1076 68/662 98/924 136/1211 
OR (95% CI) - Ref. 0.91 (0.59-1.24) Ref. 0.94 (0.64-1.25) 
Weight loss; n events/total 33/395 74/1071 58/664 61/924 104/1206 
OR (95% CI) 1.20 (0.61-1.79) Ref. 1.12 (0.67-1.57) Ref. 1.00 (0.62-1.38) 
Weakness; n events/total 84/397 258/1072 205/668 197/924 350/1213 
OR (95% CI) 0.73 (0.49-0.97)† Ref. 1.63 (1.22-2.05) Ref. 1.46 (1.11-1.80) 
 
Analyses adjusted as in model 3 in table 3. Categories of adjustment variables area as in table 1 for the Seniors-
ENRICA cohort and as in table 2 for the Toledo Study on Healthy Aging.  
aNA: Data were not calculated due to the small number of events in these categories (N<10). 
† I2 ≥30%; Data should be interpreted with caution. 
